Related references
Note: Only part of the references are listed.SGLT2 Inhibition with Empagliflozin as a Possible Therapeutic Option for Postprandial Hypoglycemia After Bariatric Surgery
Giovanna B. Carpentieri et al.
OBESITY SURGERY (2022)
Study protocol for a randomised, double-blind, placebo-controlled crossover trial assessing the impact of the SGLT2 inhibitor empagliflozin on postprandial hypoglycaemia after gastric bypass
Antonio Ferreira et al.
BMJ OPEN (2022)
Medical Nutrition Therapy and Other Approaches to Management of Post-bariatric Hypoglycemia: A Team-Based Approach
Nicole Patience et al.
CURRENT OBESITY REPORTS (2022)
Roux-en-Y Gastric Bypass Increases Glycemic Variability and Time in Hypoglycemia in Patients With Obesity and Prediabetes or Type 2 Diabetes: A Prospective Cohort Study
Ibiyemi Ilesanmi et al.
DIABETES CARE (2021)
Symptomatic Hypoglycemia After Gastric Bypass: Incidence and Predictive Factors in a Cohort of 1,138 Consecutive Patients
Rebecca Bienvenot et al.
OBESITY (2021)
Glycemic Patterns Are Distinct in Post-Bariatric Hypoglycemia After Gastric Bypass (PBH-RYGB)
Daniel Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Canagliflozin: A New Therapeutic Option in Patients That Present Postprandial Hyperinsulinemic Hypoglycemia after Roux-en-Y Gastric Bypass: A Pilot Study
Andreea Ciudin et al.
OBESITY FACTS (2021)
SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action
Milton Packer
DIABETES CARE (2020)
The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery
Christoffer Martinussen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Postprandial Hypoglycemia in Patients after Gastric Bypass Surgery Is Mediated by Glucose-Induced IL-1β
Matthias Hepprich et al.
CELL METABOLISM (2020)
International consensus on the diagnosis and management of dumping syndrome
Emidio Scarpellini et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study
Lena M. S. Carlsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide
Caroline Christfort Ohrstrom et al.
DIABETES OBESITY & METABOLISM (2019)
Mechanisms of action of a carbohydrate-reduced, high-protein diet in reducing the risk of postprandial hypoglycemia after Roux-en-Y gastric bypass surgery
Daniel Kandel et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2019)
Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass
Jonathan Q. Purnell et al.
DIABETOLOGIA (2018)
The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
Merlin C. Thomas et al.
DIABETOLOGIA (2018)
Incidence of Hypoglycemia After Gastric Bypass vs Sleeve Gastrectomy: A Randomized Trial
Esmeralda Capristo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies
Marzieh Salehi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures
Luigi Angrisani et al.
OBESITY SURGERY (2018)
Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Stephanie A. Amiel et al.
DIABETES CARE (2017)
Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia
Colleen M. Craig et al.
DIABETOLOGIA (2017)
Diabetes remission after bariatric surgery is characterized by high glycemic variability and high oxidative stress
G. Nosso et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2017)
Medical nutrition therapy for post-bariatric hypoglycemia: practical insights
Emmy Suhl et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2017)
Empagliflozin and Kinetics of Renal Glucose Transport in Healthy Individuals and Individuals With Type 2 Diabetes
Hussein Al-Jobori et al.
DIABETES (2017)
Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1)
Susanne Famulla et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2017)
Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
Flavio A. Cadegiani et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2016)
Glycemic Variability on Continuous Glucose Monitoring System Correlates With Non-Culprit Vessel Coronary Plaque Vulnerability in Patients With First-Episode Acute Coronary Syndrome
Masaomi Gohbara et al.
CIRCULATION JOURNAL (2015)
Blockade of Glucagon-like Peptide 1 Receptor Corrects Postprandial Hypoglycemia After Gastric Bypass
Marzieh Salehi et al.
GASTROENTEROLOGY (2014)
Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals
Siv H. Jacobsen et al.
DIABETOLOGIA (2013)
Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
Leo Seman et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2013)
Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
R. Grempler et al.
DIABETES OBESITY & METABOLISM (2012)
Usefulness of Acarbose and Dietary Modifications to Limit Glycemic Variability Following Roux-en-Y Gastric Bypass as Assessed by Continuous Glucose Monitoring
Patrick Ritz et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2012)
High Glycemic Variability Assessed by Continuous Glucose Monitoring After Surgical Treatment of Obesity by Gastric Bypass
Helene Hanaire et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Calculating the Mean Amplitude of Glycemic Excursion from Continuous Glucose Monitoring Data: An Automated Algorithm
Peter A. Baghurst
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells
B. Schisano et al.
DIABETOLOGIA (2011)
Relationships Between Daily Acute Glucose Fluctuations and Cognitive Performance Among Aged Type 2 Diabetic Patients
Maria Rosaria Rizzo et al.
DIABETES CARE (2010)
SGLT2 inhibition - a novel strategy for diabetes treatment
Edward C. Chao et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes
L Monnier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Share Paper
